CryoCell

LOAN REPAID

OPPORTUNITY OVERVIEW
A private cord blood storage company with over $21 million of revenue is raising a total of $10,650,000 of debt.

  • $10,000,000 of senior debt
  • $650,000 of subordinated debt

12.00% Total Interest (gross)
$650,000 Total Availability

  • Total Loan Size: $650,000
  • Cash Interest Rate (net, annualized): 10.8%
  • Loan Priority: Subordinated
  • Term Length: 5 years
  • Interest Frequency: Monthly
  • Loan Amortization: Monthly

LOAN FULLY REPAID – JUNE 2017

COMPANY OVERVIEW
The Company provides processing and cryogenic storage of cord blood and cord tissue specimens for newborn babies, preserving their cord blood stem cells for future use. The Company is over 20 years old and currently stores more than 100,000 specimens.

INVESTMENT HIGHLIGHTS

  • Industry Leader: The Company’s cord blood storage holds more cord blood patents than any other private cord blood bank. The Company’s collection, processing and cryopreservation methods safeguard stem cells 30x longer than other private cord blood banks.
  • Recurring Revenue: The majority of the Company’s profit is derived from an annual storage fees. In 2015, the Company collected the majority of its revenue from subscribers’ annual storage fees.
  • Low Marginal Costs: After the initial intake and processing costs, there are very little incremental ongoing storage costs.

FOR ADDITIONAL DETAILS, PLEASE LOGIN.

Existing Users Log In